TRCT
INVA icon

Tower Research Capital (TRC)’s Innoviva INVA Stock Holding History

Tower Research Capital (TRC)’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132K Buy
5,674
+4,357
+331% +$93.9K ﹤0.01% 1964
2025
Q4 		$26.3K Sell
1,317
-913
-41% -$17.8K ﹤0.01% 2895
2025
Q3 		$40.7K Sell
2,230
-4,677
-68% -$91.2K ﹤0.01% 2701
2025
Q2 		$139K Buy
6,907
+6,214
+897% +$120K ﹤0.01% 2108
2025
Q1 		$12.6K Sell
693
-4,269
-86% -$76.5K ﹤0.01% 3440
2024
Q4 		$86.1K Buy
4,962
+2,128
+75% +$40.9K ﹤0.01% 2230
2024
Q3 		$54.7K Sell
2,834
-12,013
-81% -$221K ﹤0.01% 2674
2024
Q2 		$243K Buy
14,847
+13,886
+1,445% +$215K ﹤0.01% 1921
2024
Q1 		$14.6K Sell
961
-11,256
-92% -$177K ﹤0.01% 3300
2023
Q4 		$196K Sell
12,217
-605
-5% -$8.46K ﹤0.01% 2108
2023
Q3 		$167K Buy
12,822
+9,087
+243% +$118K 0.01% 1561
2023
Q2 		$47.5K Buy
3,735
+1,548
+71% +$19.4K ﹤0.01% 2624
2023
Q1 		$24K Buy
2,187
+1,384
+172% +$16.8K ﹤0.01% 3240
2022
Q4 		$10K Sell
803
-23,576
-97% -$310K ﹤0.01% 4019
2022
Q3 		$283K Buy
24,379
+19,044
+357% +$261K ﹤0.01% 1599
2022
Q2 		$79K Sell
5,335
-3,701
-41% -$60.6K ﹤0.01% 2474
2022
Q1 		$175K Buy
9,036
+7,882
+683% +$141K ﹤0.01% 1829
2021
Q4 		$20K Sell
1,154
-929
-45% -$15.8K ﹤0.01% 3663
2021
Q3 		$35K Sell
2,083
-1,278
-38% -$19.1K ﹤0.01% 3238
2021
Q2 		$45K Sell
3,361
-4,126
-55% -$51.6K ﹤0.01% 3105
2021
Q1 		$90K Buy
7,487
+5,025
+204% +$60.8K ﹤0.01% 2669
2020
Q4 		$31K Sell
2,462
-41,970
-94% -$453K ﹤0.01% 3541
2020
Q3 		$464K Buy
44,432
+28,215
+174% +$359K 0.01% 1757
2020
Q2 		$226K Buy
+16,217
New +$221K 0.01% 1692
2020
Q1 		– Sell
-792
Closed -$11K – 3461
2019
Q4 		$11K Buy
792
+729
+1,157% +$8.94K ﹤0.01% 2282
2019
Q3 		$1K Buy
+63
New +$753 ﹤0.01% 3875
2019
Q2 		– Sell
-760
Closed -$11K – 3967
2019
Q1 		$11K Buy
760
+596
+363% +$9.65K ﹤0.01% 2636
2018
Q4 		$3K Buy
+164
New +$2.66K ﹤0.01% 3192
2018
Q2 		– Sell
-501
Closed -$8K – 3856
2018
Q1 		$8K Buy
+501
New +$7.73K ﹤0.01% 2548
2017
Q4 		– Sell
-9,229
Closed -$130K – 3745
2017
Q3 		$130K Buy
+9,229
New +$122K 0.01% 1116
2017
Q1 		– Sell
-200
Closed -$2K – 3465
2016
Q4 		$2K Buy
+200
New +$2.1K ﹤0.01% 3422
2016
Q3 		– Sell
-1,908
Closed -$21K – 4019
2016
Q2 		$21K Buy
1,908
+1,642
+617% +$19.4K ﹤0.01% 2191
2016
Q1 		$3K Buy
266
+124
+87% +$1.36K ﹤0.01% 3106
2015
Q4 		$1K Sell
142
-8,132
-98% -$74.8K ﹤0.01% 4092
2015
Q3 		$59K Buy
+8,274
New +$112K 0.01% 902
2014
Q4 		– Sell
-906
Closed -$15K – 4322
2014
Q3 		$15K Buy
906
+696
+331% +$16K ﹤0.01% 2541
2014
Q2 		$6K Buy
210
+73
+53% +$1.75K ﹤0.01% 2718
2014
Q1 		$3K Sell
137
-1,595
-92% -$46.7K ﹤0.01% 3634
2013
Q4 		$50K Buy
1,732
+693
+67% +$20.3K 0.01% 1396
2013
Q3 		$34K Sell
1,039
-1,207
-54% -$37.5K ﹤0.01% 2248
2013
Q2 		$70K Buy
+2,246
New +$60.3K 0.01% 700

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s INVA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Innoviva (INVA) stake by 331% in Q1 2026, buying an estimated $93.9K and bringing the position to 5,674 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Tower Research Capital (TRC) first reported a position in INVA in Q2 2013 and has held it in 41 quarters since. The position peaked at $464K in Q3 2020. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Tower Research Capital (TRC) held 5,674 shares of Innoviva worth $132K as of Q1 2026.
  • Tower Research Capital (TRC) bought 4,357 Innoviva shares in Q1 2026, an estimated $93.9K.
  • Innoviva made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1964 holding.
  • Tower Research Capital (TRC) first reported a position in Innoviva in Q2 2013 and has held it in 41 quarters since.
  • Tower Research Capital (TRC)'s Innoviva position peaked at $464K in Q3 2020.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.